Drawing for KITE DUOCORE

USPTO serial 99558353

KITE DUOCORE

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
GALANTE, JOSHUA MICHAEL
Law office
TMO LAW OFFICE 127

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KITE DUOCORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia Smuzynska

Cynthia Smuzynska Gilead Sciences, Inc.333 Lakeside DriveFoster City, CA 94404United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer and tumors, and autoimmune diseases and disorders; Biological preparations for the treatment of cancer; Biologics in the nature of pharmaceutical preparations for the treatment of cancer and autoimmune diseasesACTIVE—
040Custom manufacture of biopharmaceuticals; Custom biomanufacturing of pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 24, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 24, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Apr 24, 2026CNSLSUSPENSION LETTER WRITTEN—
Apr 23, 2026DOCKASSIGNED TO EXAMINER—
Apr 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 19, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance